Related Experiment Video
Updated: Jun 30, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs
Shraddha Chugh1, Mousmee Sharma2, Harish Mudila3
1Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.
Abstract:
Aim: Amide-linked amylose-based prodrugs were developed for colon-targeted release of mefenamic acid. Materials & methods: Activation of prodrug was studied spectrophotometrically, enzyme-linked immunosorbent assay appraised cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibition at different concentrations of the prodrug, the behavior of prodrug under physiological conditions was monitored by scanning electron microscopy. Results: Prodrug was poorly activated in the enzyme-free simulated gastric media and simulated intestinal media (SIM) but preincubation in pancreatin followed by treatment in aminopeptidase containing SIM led to a significant activation of prodrug. Conclusion: Amide-linked amylose-mefenamic acid conjugates showed a slow release in simulated gastric media and a controlled release in SIM with pancreatin playing an important role in drug release.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Prodrugs
Prodrugs help overcome...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drugs for Treatment of Ulcerative Colitis in IBD
Phase II Conjugation Reactions: Overview

